These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 11900277

  • 1. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Yorek MA.
    Int J Exp Diabetes Res; 2002; 3(1):21-36. PubMed ID: 11900277
    [Abstract] [Full Text] [Related]

  • 2. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.
    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Yorek MA.
    Diabetes; 2001 Aug; 50(8):1927-37. PubMed ID: 11473057
    [Abstract] [Full Text] [Related]

  • 3. Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Salvemini D, Yorek MA.
    Br J Pharmacol; 2001 Sep; 134(1):21-9. PubMed ID: 11522593
    [Abstract] [Full Text] [Related]

  • 4. Changes in endoneurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF-obese diabetic rats.
    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Yorek MA.
    Diabetes Metab Res Rev; 2002 Sep; 18(1):49-56. PubMed ID: 11921418
    [Abstract] [Full Text] [Related]

  • 5. Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve.
    Coppey LJ, Davidson EP, Dunlap JA, Lund DD, Yorek MA.
    Int J Exp Diabetes Res; 2000 Sep; 1(2):131-43. PubMed ID: 11469397
    [Abstract] [Full Text] [Related]

  • 6. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K, Kato N, Matsubara A, Nakano K, Kurono M.
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [Abstract] [Full Text] [Related]

  • 7. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism.
    Cameron NE, Cotter MA, Dines KC, Maxfield EK, Carey F, Mirrlees DJ.
    Diabetologia; 1994 Jul; 37(7):651-63. PubMed ID: 7958535
    [Abstract] [Full Text] [Related]

  • 8. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
    Gillon KR, Hawthorne JN, Tomlinson DR.
    Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
    [Abstract] [Full Text] [Related]

  • 9. Effect of fidarestat and alpha-lipoic acid on diabetes-induced epineurial arteriole vascular dysfunction.
    Yorek MA, Coppey LJ, Gellett JS, Davidson EP, Lund DD.
    Exp Diabesity Res; 2004 Oct; 5(2):123-35. PubMed ID: 15203883
    [Abstract] [Full Text] [Related]

  • 10. Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity.
    Greene DA, Lattimer SA.
    Diabetes; 1984 Aug; 33(8):712-6. PubMed ID: 6086432
    [Abstract] [Full Text] [Related]

  • 11. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR, Moriarty RJ, Mayer JH.
    Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
    [Abstract] [Full Text] [Related]

  • 12. Reduced motor nerve conduction velocity and Na(+)-K(+)-ATPase activity in rats maintained on L-fucose diet. Reversal by myo-inositol supplementation.
    Yorek MA, Wiese TJ, Davidson EP, Dunlap JA, Stefani MR, Conner CE, Lattimer SA, Kamijo M, Greene DA, Sima AA.
    Diabetes; 1993 Oct; 42(10):1401-6. PubMed ID: 8397126
    [Abstract] [Full Text] [Related]

  • 13. Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation.
    Coppey LJ, Gellett JS, Davidson EP, Yorek MA.
    Free Radic Res; 2003 Jan; 37(1):33-40. PubMed ID: 12653215
    [Abstract] [Full Text] [Related]

  • 14. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
    Cotter MA, Cameron NE, Hohman TC.
    J Peripher Nerv Syst; 1998 Jan; 3(3):217-23. PubMed ID: 10959252
    [Abstract] [Full Text] [Related]

  • 15. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
    Obrosova IG, Pacher P, Szabó C, Zsengeller Z, Hirooka H, Stevens MJ, Yorek MA.
    Diabetes; 2005 Jan; 54(1):234-42. PubMed ID: 15616034
    [Abstract] [Full Text] [Related]

  • 16. The effects of sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin-diabetic rat.
    Cameron NE, Leonard MB, Ross IS, Whiting PH.
    Diabetologia; 1986 Mar; 29(3):168-74. PubMed ID: 3084324
    [Abstract] [Full Text] [Related]

  • 17. Effect of a new aldose reductase inhibitor, 8'-chloro-2',3'-dihydrospiro [pyrrolidine-3,6'(5'H)-pyrrolo[1,2,3-de] [1,4]benzoxazine]-2,5,5'- trione (ADN-138), on delayed motor nerve conduction velocity in streptozotocin-diabetic rats.
    Hirata Y, Fujimori S, Okada K.
    Metabolism; 1988 Feb; 37(2):159-63. PubMed ID: 2828821
    [Abstract] [Full Text] [Related]

  • 18. Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats.
    Raccah D, Coste T, Cameron NE, Dufayet D, Vague P, Hohman TC.
    J Diabetes Complications; 1998 Feb; 12(3):154-62. PubMed ID: 9618071
    [Abstract] [Full Text] [Related]

  • 19. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition.
    Greene DA, Mackway AM.
    Diabetes; 1986 Oct; 35(10):1106-8. PubMed ID: 3019804
    [Abstract] [Full Text] [Related]

  • 20. Reduced nerve blood flow in diabetic rats: relationship to nitric oxide production and inhibition of aldose reductase.
    Tomlinson DR, Dewhurst M, Stevens EJ, Omawari N, Carrington AL, Vo PA.
    Diabet Med; 1998 Jul; 15(7):579-85. PubMed ID: 9686698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.